NDC 55150-391 – Bendamustine Hydrochloride
Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC55150-391
Product details
- Brand name
- Bendamustine Hydrochloride
- Generic name
- Bendamustine Hydrochloride
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA214739
- Marketed since
- June 5, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Bendamustine Hydrochloride 25 mg/5mL
Uses, dosage, side effects and warnings for Bendamustine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-391-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-391-01) / 5 mL in 1 VIAL, SINGLE-DOSE | Jun 5, 2023 |
Other Bendamustine Hydrochloride products
- 16729-250 Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 16729-251 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 68001-572 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 55150-392 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 60505-6228 Bendamustine Hydrochloride 25 mg/mL · Injection, Solution · Apotex Corp
- 83831-183 Bendamustine Hydrochloride 100 mg/4mL · Injection · Avyxa Pharma, LLC
- 10019-079 Bendamustine Hydrochloride 100 mg/1 · Injection · Baxter Healthcare Corporation